Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Impax Laboratories Inc    IPXL   US45256B1017

News SummaryMost relevantAll newsSector news 

Impax Laboratories Inc : Impax Laboratories to Present at the UBS Global Healthcare Conference

05/20/2013 | 07:35am US/Eastern

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the UBS Global Healthcare Conference on Wednesday, May 22, at 9:00 a.m. Eastern Standard Time. The conference will be held at the Sheraton New York Hotel.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at:

Impax Laboratories, Inc.
Mark Donohue, 215-558-4526
Investor Relations and Corporate Communications

© Business Wire 2013
React to this article
04/16 IMPAX LABORATORIES : to Report First Quarter 2015 Results on May 11, 2015
04/09 IMPAX ASSET MANAGEMENT : Reports Higher Assets Under Management Over Second Quar..
03/31 IMPAX ENVIRONMENTAL MARKETS : NAV Underperforms, Ups Dividend As Profit Improves
03/25 IMPAX LABORATORIES : Amendments to Articles of Inc. or Bylaws; Change in Fiscal ..
03/12 IMPAX LABORATORIES : Entry into a Material Definitive Agreement, Creation of a D..
03/11 IMPAX LABORATORIES : Justification and Approval - N-- Emergency onsite installat..
03/10 IMPAX LABORATORIES : Completion of Acquisition or Disposition of Assets, Results..
03/10 IMPAX LABORATORIES : to Present at the Cowen and Company 35th Annual Health Care..
02/26 IMPAX LABORATORIES : Management's Discussion and Analysis of Financial Condition..
02/25 IMPAX LABORATORIES : Revenues Increased 30% to $131 Million in Fourth Quarter 20..
Duration : Period :
Impax Laboratories Inc Technical Analysis Chart | IPXL | US45256B1017 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes